The effects of add-on therapy of DPP4 inhibitor, Vildagliptin, on glucose control and diabetic complication in type 2 diabetes mellitus treated with insulin administration
Phase of Trial: Phase IV
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Vildagliptin (Primary) ; Insulin
- Indications Diabetic nephropathies; Diabetic retinopathy; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 09 Mar 2017 Status changed from active, no longer recruiting to completed.
- 07 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.